Nantahala Capital Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-77,340	Closed	-$31.8K	–	145
2024 Q3	$31.8K	Hold	77,340	–	–	﹤0.01%	118
2024 Q2	$58.7K	Sell	77,340 -11,200	-13%	-$8.5K	﹤0.01%	114
2024 Q1	$147K	Sell	88,540 -31,592	-26%	-$52.4K	0.01%	101
2023 Q4	$305K	Sell	120,132 -16,351	-12%	-$41.5K	0.02%	100
2023 Q3	$382K	Sell	136,483 -9,749	-7%	-$27.3K	0.03%	96
2023 Q2	$679K	Sell	146,232 -4,832,743	-97%	-$22.4M	0.07%	87
2023 Q1	$3.19M	Sell	4,978,975 -1,073,892	-18%	-$687K	0.24%	55
2022 Q4	$3.51M	Sell	6,052,867 -835,955	-12%	-$485K	0.23%	50
2022 Q3	$4.1M	Sell	6,888,822 -343,854	-5%	-$205K	0.27%	42
2022 Q2	$5.37M	Sell	7,232,676 -89,513	-1%	-$66.4K	0.27%	46
2022 Q1	$9.96M	Sell	7,322,189 -282,504	-4%	-$384K	0.44%	32
2021 Q4	$10.3M	Buy	7,604,693 +248,963	+3%	+$336K	0.36%	40
2021 Q3	$16M	Sell	7,355,730 -185,767	-2%	-$405K	0.51%	33
2021 Q2	$25M	Sell	7,541,497 -197,395	-3%	-$655K	0.71%	24
2021 Q1	$46.2M	Buy	7,738,892 +466,219	+6%	+$2.79M	1.35%	10
2020 Q4	$31.9M	Buy	7,272,673 +383,516	+6%	+$1.68M	0.99%	19
2020 Q3	$41.3M	Buy	6,889,157 +912,305	+15%	+$5.47M	1.26%	7
2020 Q2	$37.7M	Sell	5,976,852 -322,344	-5%	-$2.03M	1.14%	12
2020 Q1	$37.4M	Buy	6,299,196 +245,366	+4%	+$1.46M	1.4%	10
2019 Q4	$34.3M	Buy	6,053,830 +1,786,300	+42%	+$10.1M	1.06%	16
2019 Q3	$8.9M	Buy	4,267,530 +855,488	+25%	+$1.78M	0.33%	44
2019 Q2	$8.91M	Buy	3,412,042 +3,350,000	+5,400%	+$8.74M	0.27%	42
2019 Q1	$125K	Buy	+62,042	New	+$125K	﹤0.01%	75